# Myocardial Hemodynamic Effects of Levosimendan

> **NCT00585104** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 10 (actual)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** levosimendan

## Key facts

- **NCT ID:** NCT00585104
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09
- **Primary completion:** 2008-12
- **Final completion:** 2008-12
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2013-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00585104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00585104, "Myocardial Hemodynamic Effects of Levosimendan". Retrieved via AI Analytics 2026-08-03 from https://api.ai-analytics.org/clinical/NCT00585104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*